Home >> General Medical Devices >> Demographics >> Food & Beverage >>

Global Neuroprosthetics Market 2015-2019 - Industry research report

Published: Sep-2015 | Format: PDF | Technavio | Number of pages: 78 | Code: MRS - 35094


Neuroprosthetics are implantable devices designed by combining neuroscience and biomedical engineering. These artificial implantable devices provide electrical stimulation that improves the functionality of a diseased nervous system. These devices either are implanted inside the body or can be worn externally. These are used either to replace a lost function of the body such as cognitive ability or to treat neurological conditions such as depression, chronic pain, epilepsy, or spinal cord injuries. Based on application, neuroprosthetics are segmented into cognitive devices and neuromodulation devices. Based on technology, neuroprosthetics are segmented into SCS system, DBS system, SNS system, VNS system, and others.

The analysts forecast global neuroprosthetics market to grow at a CAGR of 7.08% over the period 2014-2019.

Covered in this report

This report covers the current scenario and the growth prospects of the global neuroprosthetics market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of cochlear implants and neuromodulators.

Based on application, the market is segmented into the following:

  • Cognitive devices (cochlear implants)
  • Neuromodulation devices

Based on technology, the market is segmented into the following:

  • SCS system
  • DBS system
  • SNS system
  • VNS system
  • Others (transcranial magnetic stimulation, peripheral nerve stimulation, gastric electrical stimulation, diaphragm pacing, lower esophageal sphincter stimulation, and cortical stimulation systems)

The report, Global Neuroprosthetics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the Americas, APAC, and EMEA; it also covers the landscape of the global neuroprosthetics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Boston Scientific
  • Cochlear
  • MED-EL
  • Medtronic
  • Sonova
  • St. Jude Medical

Other prominent vendors

  • Autonomic Technologies
  • BrainGate
  • electroCore
  • Mainstay Medical
  • NeuroPace
  • Nevro
  • Oticon Medical
  • Soterix Medical

Key market driver

  • Growing prevalence of neurological disorder
  • For a full, detailed list, view our report

Key market challenge

  • Battery lifetime
  • For a full, detailed list, view our report

Key market trend

  • Overseas expansion
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors


Table of Contents

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Reimbursement for neuroprosthetics
Reimbursement in US
Reimbursement in Europe
Reimbursement in APAC

PART 06: Emerging technologies in neuroprosthetics
Brain-computer interface

PART 07: Recent market approvals

PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 09: Market segmentation by application
Global neuroprosthetics market segmentation by application

PART 10: Global cognitive devices market
Market overview
Market size and forecast

PART 11: Global neuromodulation devices market
Market overview
Market size and forecast

PART 12: Market segmentation by technology
Global neuroprosthetics market segmentation by technology

PART 13: Geographical segmentation
Neuroprosthetics market in Americas
Neuroprosthetics market in EMEA
Neuroprosthetics market in APAC

PART 14: Market drivers
Increased prevalence of neurological disorders
Availability of funds for R&D
Numerous product approvals
Second-line treatment

PART 15: Impact of drivers

PART 16: Market challenges
Battery lifetime
Limited compatibility with MRI, X-ray, and ultrasound equipment
Limited reimbursement scenario
GPOs as intermediary
Stringent regulations
Cost containment

PART 17: Impact of drivers and challenges

PART 18: Market trends
Overseas expansions
Hybrid neuroprosthetic devices
Next-generation therapies for CNS disorders
Aesthetically appealing prosthetics
Use in US military

PART 19: Vendor landscape
Competitive scenario
Market share analysis 2013
Other prominent vendors

PART 20: Key vendor analysis
Boston Scientific
Cochlear
MED-EL
Medtronic
Sonova
St. Jude Medical

PART 21: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Reimbursement of neuroprosthetics in US
Exhibit 03: Reimbursement of neuroprosthetics in major European countries
Exhibit 04: Emerging neuroprosthetics and approval dates
Exhibit 05: Approved neuroprosthetics 2015
Exhibit 06: Global neuroprosthetics market 2014-2019 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Global neuroprosthetics market segmentation by application 2014
Exhibit 09: Global cochlear implants market 2014-2019 ($ billions)
Exhibit 10: Global neuromodulation devices market 2014-2019 ($ billions)
Exhibit 11: Global neuroprosthetics market segmentation by technology 2014
Exhibit 12: Global SCS system market 2014-2019 ($ billions)
Exhibit 13: Global DBS system market 2014-2019 ($ millions)
Exhibit 14: Global SNS system market 2014-2019 ($ millions)
Exhibit 15: Global VNS system market 2014-2019 ($ millions)
Exhibit 16: Global neuroprosthetics market segmentation by geography 2014
Exhibit 17: Neuroprosthetics market in Americas 2014-2019 ($ millions)
Exhibit 18: Neuroprosthetics market in EMEA 2014-2019 ($ billions)
Exhibit 19: Neuroprosthetics market in APAC 2014-2019 ($ billions)
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Top vendors in cognitive devices market 2014
Exhibit 23: Cochlear: Key takeaways
Exhibit 24: MED-EL: Key takeaways
Exhibit 25: Sonova Holding: Key takeaways
Exhibit 26: Global neuromodulation devices market share analysis 2014
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: Boston Scientific: Key takeaways
Exhibit 29: St. Jude Medical: Key takeaways
Exhibit 30: Cochlear: Business segmentation by revenue 2014
Exhibit 31: Cochlear: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 32: MED-EL: Product offerings
Exhibit 33: Sonova: Business segmentation
Exhibit 34: Sonova: Business segmentation by revenue 2015
Exhibit 35: Sonova: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 36: Sonova: Geographical segmentation by revenue 2014

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing